Literature DB >> 30152569

Cyclosporine for corticosteroid-refractory acute generalized exanthematous pustulosis due to hydroxychloroquine.

Nicholas Bradford Castner1, Jessica Crabbe Harris2, Kiran Motaparthi2.   

Abstract

Acute generalized exanthematous pustulosis most often manifests 1-2 days following exposure to a characteristic drug, such as aminopenicillins, calcium-channel blockers, or terbinafine. Recovery is usually rapid following drug withdrawal, and systemic corticosteroids represent the historic treatment of choice. Herein, acute generalized exanthematous pustulosis incited by hydroxychloroquine is briefly reviewed: a prolonged latency and recalcitrance to corticosteroids are noteworthy. In this unique context, cyclosporine tapered over several months is an effective therapeutic option.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  acute generalized exanthematous pustulosis; cyclosporine; hydroxychloroquine

Mesh:

Substances:

Year:  2018        PMID: 30152569     DOI: 10.1111/dth.12660

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  3 in total

1.  Acute generalized exanthematous pustulosis induced by empiric hydroxychloroquine for presumed COVID-19.

Authors:  Tyler Enos; Haneol S Jeong; Travis Vandergriff; Heidi T Jacobe; Benjamin F Chong
Journal:  Dermatol Ther       Date:  2020-07-08       Impact factor: 3.858

Review 2.  Generalized pustular figurate erythema: A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine.

Authors:  Robert A Schwartz; Camila K Janniger
Journal:  Dermatol Ther       Date:  2020-04-16       Impact factor: 3.858

Review 3.  Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients.

Authors:  Enriqueta Vallejo-Yagüe; Adrian Martinez-De la Torre; Omar S Mohamad; Shweta Sabu; Andrea M Burden
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.